Medtech Insight is part of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC’s registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 8860726.

This copy is for your personal, non-commercial use. For high-quality copies or electronic reprints for distribution to colleagues or customers, please call +44 (0) 20 3377 3183

Printed By

UsernamePublicRestriction
UsernamePublicRestriction

MedMira's rapid HIV tests edges closer to the US:

This article was originally published in Clinica

Executive Summary

MedMira's Reveal Rapid HIV test is to enter the final leg of the US pre-market approval (PMA) process, after the company received notification of the date for a comprehensive pre-approval inspection by the FDA. If the inspection is successful, the three-minute Reveal test "would be the only such device with PMA approval in the US", said Stephen Sham, the Toronto, Ontario firm's chairman and CEO. MedMira noted that its US distributor, American Health Diagnostics, has already placed an initial order for 500,000 Reveal test kits to be shipped pending receipt of the PMA.

Advertisement

Topics

Advertisement
UsernamePublicRestriction

Register

MT065028

Ask The Analyst

Please Note: You can also Click below Link for Ask the Analyst
Ask The Analyst

Your question has been successfully sent to the email address below and we will get back as soon as possible. my@email.address.

All fields are required.

Please make sure all fields are completed.

Please make sure you have filled out all fields

Please make sure you have filled out all fields

Please enter a valid e-mail address

Please enter a valid Phone Number

Ask your question to our analysts

Cancel